Search Within

Lisa Bodei

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (60)
  3. Review (33)
  4. Book Section (17)
  5. Editorial (12)
  6. Guidelines (9)
  7. Conference Paper (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Molecular Imaging and Therapy Service (205)
  2. Radiology, Department of (205)
  3. Sloan Kettering Institute Postdocs (205)
  4. Center for Pancreatic Cancer Research (35)
  5. Department of Medicine (31)
  6. Solid Tumor Oncology Division (29)

More Groups

People
  1. Heiko Schoder (19)
  2. Jason Lewis (18)
  3. Diane Reidy (17)
  4. Joseph O'Donoghue (13)
  5. Simone Krebs (10)
  6. Michael Morris (9)

More People

Years
  1. 2025 (3)
  2. 2024 (15)
  3. 2023 (26)
  4. 2022 (16)
  5. 2021 (27)
  6. 2020 (31)

More Years

Publications
  1. Journal of Nuclear Medicine (34)
  2. Neuroendocrinology (32)
  3. European Journal of Nuclear Medicine and Molecular Imaging (26)
  4. Pancreas (16)
  5. Journal of Clinical Oncology (13)
  6. Radiopharmaceutical Therapy (9)

More Publications

Publishers
  1. Springer (48)
  2. Society of Nuclear Medicine (34)
  3. S. Karger AG (32)
  4. Lippincott Williams & Wilkins (22)
  5. American Society of Clinical Oncology (13)
  6. Elsevier Inc. (11)

More Publishers

Results (205)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The NETest: The clinical utility of multigene blood analysis in the diagnosis and management of neuroendocrine tumors
    Journal Article

    Modlin, I. M.; Kidd, M.; Malczewska, A.; Drozdov, I.; Bodei, L.; Matar, S.; Chung, K. M.
    Endocrinology and Metabolism Clinics of North America (2018)

    Fulltext@MSK | Save
  • A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
    Journal Article

    Alvarez, M. J.; Subramaniam, P. S.; Tang, L. H.; Grunn, A.; Aburi, M.; Rieckhof, G.; Komissarova, E. V.; Hagan, E. A.; Bodei, L.; Clemons, P. A.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save
  • PRRT genomic signature in blood for prediction of (177)Lu-octreotate efficacy
    Journal Article

    Bodei, L.; Kidd, M. S.; Singh, A.; van der Zwan, W. A.; Severi, S.; Drozdov, I. A.; Cwikla, J.; Baum, R. P.; Kwekkeboom, D. J.; Paganelli, G.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Somatostatin receptor imaging of neuroendocrine tumors: From agonists to antagonists
    Journal Article

    Bodei, L.; Weber, W. A.
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • The clinical utility of blood neuroendocrine gene transcript measurement in defining surgical resection and residual disease in bronchopulmonary neuroendocrine tumors
    Meeting Abstract

    Filosso, P. L.; Kidd, M.; Roffinella, M.; Chung, K. M.; Lewczuk, A.; Kolasinska-Cwikla, A.; Cwikla, J.; Malczewska, A.; Tesselaar, M.; Kos-Kudla, B.; more...
    Pancreas (2018)

    Fulltext@MSK | Save
  • Chromogranin A is an inadequate circulating biomarker for bronchopulmonary neuroendocrine neoplasia management
    Meeting Abstract

    Malczewska, A.; Kidd, M.; Matar, S.; Lewczuk, A.; Kolasinska-Cwikla, A.; Cwikla, J.; Bodei, L.; Kos-Kudla, B.; Modlin, I.
    Pancreas (2018)

    Fulltext@MSK | Save
  • Blood neuroendocrine transcript analysis for the diagnosis and clinical status assessment of bronchopulmonary neuroendocrine tumors
    Meeting Abstract

    Modlin, I.; Kidd, M.; Lewczuk, A.; Chung, K. M.; Kolasinska-Cwikla, A.; Cwikla, J.; Tesselaar, M.; Malczewska, A.; Kos-Kudla, B.; Bodei, L.; more...
    Pancreas (2018)

    Fulltext@MSK | Save
  • The Predictive Quotient Index comprising gene cluster analysis and grading is specifically predictive of PRRT efficacy
    Meeting Abstract

    Bodei, L.; Kidd, M.; van der Zwan, W.; Singh, A.; Severi, S.; Drozdov, I.; Cwikla, J.; Kolasinska-Cwikla, A.; Baum, R.; Kwekkeboom, D.; more...
    Pancreas (2018)

    Fulltext@MSK | Save
  • Phase 1/2 open-label trial to assess the safety and preliminary efficacy of (177)Lu-OPS201 as peptide receptor radionuclide therapy in patients with somatostatin receptor-positive, progressive neuroendocrine tumors
    Meeting Abstract

    Nicolas, G.; Bodei, L.; Baum, R.; Herrmann, K.; Lassmann, M.; Hicks, R.; Navalkissoor, S.; Haug, A.; Oberwittler, H.; Wang, T.; more...
    Pancreas (2018)

    Fulltext@MSK | Save
  • Theranostic trial of well differentiated neuroendocrine tumors (NETs) with 68Ga-OPS201 and 177Lu-OPS201
    Meeting Abstract

    Reidy-Lagunes, D.; Pandit-Taskar, N.; Krebs, S.; O'Donoghue, J.; Raj, N. P.; Cruz, E.; Pham, H.; Lashley, A.; Bodei, L.; Weber, W.
    Pancreas (2018)

    Fulltext@MSK | Save